These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10932625)

  • 1. [Importance of knowledge of information on adverse effects and interactions of drugs].
    Stanimirović V; Babić M; Cucak S; Nikolić D; Nikolić A
    Srp Arh Celok Lek; 2000; 128(3-4):135-9. PubMed ID: 10932625
    [No Abstract]   [Full Text] [Related]  

  • 2. Avoiding drug interactions.
    Prescrire Int; 2004 Jun; 13(71):99-102. PubMed ID: 15233147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug interactions in an intensive care unit].
    Nielsen EW; Dybwik K
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2907-8. PubMed ID: 15550963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Unwanted drug interactions. Keeping up pharmacovigilance using databases].
    Schindler B
    Med Monatsschr Pharm; 2008 Apr; 31(4):155-6. PubMed ID: 18497254
    [No Abstract]   [Full Text] [Related]  

  • 5. Network analysis of adverse drug interactions.
    Takarabe M; Okuda S; Itoh M; Tokimatsu T; Goto S; Kanehisa M
    Genome Inform; 2008; 20():252-9. PubMed ID: 19425139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Architecture of the drug-drug interaction network.
    Hu TM; Hayton WL
    J Clin Pharm Ther; 2011 Apr; 36(2):135-43. PubMed ID: 21366641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herbal remedies: drug-herb interactions.
    Kuhn MA
    Crit Care Nurse; 2002 Apr; 22(2):22-8, 30, 32; quiz 34-5. PubMed ID: 11961942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear neural mapping analysis of the adverse effects of drugs.
    Domine D; Guillon C; Devillers J; Lacroix R; Lacroix J; Doré JC
    SAR QSAR Environ Res; 1998; 8(1-2):109-20. PubMed ID: 9517012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing dangerous drug interactions.
    Piscitelli S
    J Am Pharm Assoc (Wash); 2000; 40(5 Suppl 1):S44-5. PubMed ID: 11029865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of drugs on the diagnostic laboratory tests results].
    Olczyk P; Olczyk K; Koźma EM; Komosińska-Vassev K; Olczyk M; Dabrowska E
    Przegl Lek; 2005; 62(2):128-32. PubMed ID: 16095160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse effects of drugs: mechanisms and factors affecting their occurrence].
    Mèszàros J
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1615-20. PubMed ID: 6679086
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adverse effects and drug interactions].
    Perlík F
    Cas Lek Cesk; 2004; 143(2):110-3. PubMed ID: 15077574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
    Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW
    Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Direct reporting of side effects by the patient: favourable experience in the first year].
    van Grootheest AC; Passier JL; van Puijenbroek EP
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):529-33. PubMed ID: 15782689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions in dermatological practice.
    Tey HL; Tian EL; Tan AW
    Clin Exp Dermatol; 2008 Aug; 33(5):541-50. PubMed ID: 18801094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinically relevant drug interactions in the elderly].
    Jansen PA
    Ned Tijdschr Geneeskd; 2003 Mar; 147(13):595-9. PubMed ID: 12701392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced funding of pharmacoepidemiology through patenting the disclosure of adverse event information.
    Classen JB
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):390-3. PubMed ID: 16411171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.
    Bate A; Lindquist M; Edwards IR
    Fundam Clin Pharmacol; 2008 Apr; 22(2):127-40. PubMed ID: 18248442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.